Total Funding
64
68
Total FundingSeries A raised
Growth Score
-8 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17070
Altoida is creating a new gold standard in brain health with Precision Neurology.
- Ioannis Tarnanas: Founder & CSO (Chief Science Officer)Past Role: ETH Zurich, Senior Fellow
- Maximilian Bügler: Chief Technology Officer (CTO)
About the Company
Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet.
Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR),
and artificial intelligence (AI).
Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.
